MicroRNA-208a Silencing Attenuates Doxorubicin Induced Myocyte Apoptosis and Cardiac Dysfunction

Figure 2

Doxorubicin caused cardiac dysfunction, while antagomir treatment improved cardiac function. (a) Representative images show doxorubicin decreased cardiac function in controls, while antagomir treatment improved cardiac function compared to control. (b) Graph shows doxorubicin decreased cardiac function, , while miR-208a antagomir treatment improved cardiac function compared to controls, .

(a)

(b)